This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Centre National De La Recherche Scientifique, National Institute of Health and Medical Research, Université Paul Sabatier (Toulouse III). Active years: 2018.
Company Filing History:
1 out of 5,383 
1 out of 1,853 
1 out of 160 
Years Active: 2018
Title: Severine Fruchon: Innovator in Anti-Inflammatory Drug Development
Introduction
Severine Fruchon is a notable inventor based in Toulouse, France. She has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-inflammatory drugs. Her innovative work has garnered attention in both academic and research institutions.
Latest Patents
Severine Fruchon holds a patent for "Phosphorylated dendrimers as anti-inflammatory drugs." This patent focuses on dendrimers with monophosphonic or bisphosphonic terminations for the treatment of inflammatory diseases. This groundbreaking work highlights her commitment to advancing medical science and improving patient outcomes.
Career Highlights
Throughout her career, Severine has been associated with prestigious institutions such as Université Paul Sabatier (Toulouse III) and the National Institute of Health and Medical Research. Her work in these organizations has allowed her to collaborate with leading experts in her field and contribute to significant advancements in medical research.
Collaborations
Severine has worked alongside esteemed colleagues, including Cédric-Olivier Turrin and Jean-Jacques Fournie. These collaborations have further enriched her research and expanded the impact of her innovations in the pharmaceutical industry.
Conclusion
Severine Fruchon is a pioneering inventor whose work in anti-inflammatory drug development is making a difference in the medical field. Her dedication to research and innovation continues to inspire future advancements in healthcare.